Fig. 7
From: Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice
RGD-exo:miR-210 administration promoted angiogenesis in the ischemic brain. a Analysis of VEGF expression in the lesion region 7 or 14 days after reperfusion and administration of RGD-exo:NC or RGD-exo:miR-210. b Quantitation of VEGF expression 7 or 14 days after reperfusion and administration. N ≥ 3. The data are presented as the mean ± SEM. *P < 0.05 and **P < 0.01 by one-way ANOVA